Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences

Support Care Cancer. 2022 Nov;30(11):8619-8621. doi: 10.1007/s00520-022-06995-7. Epub 2022 Mar 21.

Authors

Luis Vitetta^{1

2}, Jason F Sikali^{3

4}, Courtney Fletcher⁴, Jeremy D Henson^{4

5}

Affiliations

¹ Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. luis.vitetta@sydney.edu.au.
² Research Department, Medlab Clinical, Sydney, Australia. luis.vitetta@sydney.edu.au.
³ Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
⁴ Research Department, Medlab Clinical, Sydney, Australia.
⁵ Prince of Wales Clinical School, The University of New South Wales, Sydney, Australia.

PMID: 35312856
DOI: 10.1007/s00520-022-06995-7

No abstract available

Keywords: Cannabidiol (CBD); Cannabinoids; Cannabis-based medicines; Oral cannabis; Smoked cannabis; Δ9-tetrahydrocannabinol (Δ9-THC).

Publication types

Letter
Comment

MeSH terms

Analgesics
Cannabis*
Cross-Sectional Studies
Denmark / epidemiology
Humans
Neoplasms*
Patient Outcome Assessment
Quality of Life

Substances

Analgesics